RTG 400 (Potiga 400 mg)
Generic Name: ezogabine
Pill with imprint RTG 400 is Purple, Rectangle and has been identified as Potiga 400 mg. It is supplied by GlaxoSmithKline.
Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 400 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for RTG 400
Potiga
- Generic Name:
- ezogabine
- Imprint:
- RTG 400
- Strength:
- 400 mg
- Color:
- Purple
- Size:
- 18.00 mm
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Neuronal potassium channel openers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0814
- Inactive Ingredients:
-
- cochineal
- croscarmellose sodium
- FD&C Blue No. 2
- hypromelloses
- soya lecithin
- magnesium stearate
- microcrystalline cellulose
- polyvinyl alcohol
- magnesium silicate
- titanium dioxide
- xanthan gum
Note: Inactive ingredients may vary.
More about Potiga (ezogabine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: neuronal potassium channel openers
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
